keyword
https://read.qxmd.com/read/38237506/medicating-the-coast-in-a-metropolitan-city-enantiomeric-profiles-and-joint-probabilistic-risk-assessment-of-antidepressants-and-antihistamines
#41
JOURNAL ARTICLE
Rongben Wu, Esther Yan-Yin Sin, Kai Zhang, Shaopeng Xu, Yuefei Ruan, Yim Ling Mak, Ying-Kit Yung, Sunny Wai-Choi Sun, Rong Yang, Paul K S Lam
Pharmaceuticals are receiving increasing attention as emerging contaminants in the aquatic environment. Herein, we investigated the occurrence of 11 antidepressants, 6 antihistamines and 4 metabolites in treated wastewater effluents, rivers, stormwater, and seawater in Hong Kong, with special focus on chirality. The average levels of ∑pharmaceuticals ranged from 0.525 to 1070 ng/L in all samples and the total annual mass load of target pharmaceuticals in the marine environment of Hong Kong was 756 kg/y...
January 9, 2024: Environment International
https://read.qxmd.com/read/38217071/pharmacokinetics-of-a-single-transdermal-dose-of-mirtazapine-in-rhesus-macaques-macaca-mulatta
#42
JOURNAL ARTICLE
David W Bissinger, Luke A Wittenburg, Laura M Garzel, Diane E Stockinger, Gregory B Timmel
Decreased appetite is a common clinical problem in captive rhesus macaques ( Macaca mulatta ). Mirtazapine, a tetracyclic antidepressant originally developed for humans, has shown promise as a safe and effective promoter of weight gain and appetite in several veterinary species including rhesus and cynomolgus macaques. Although mirtazapine is available as oral formulations, transdermal delivery in macaques with reduced appetite would allow quick, painless, topical application. Here we describe the pharmacokinetics of a single application of a widely available veterinary transdermal mirtazapine formulation in 6 rhesus macaques...
December 1, 2023: Comparative Medicine
https://read.qxmd.com/read/38206631/mirtazapine-as-appetite-stimulant-in-patients-with-non-small-cell-lung-cancer-and-anorexia-a-randomized-clinical-trial
#43
RANDOMIZED CONTROLLED TRIAL
Oscar Arrieta, Daniela Cárdenas-Fernández, Oscar Rodriguez-Mayoral, Salvador Gutierrez-Torres, Diana Castañares, Diana Flores-Estrada, Edgar Reyes, Dennis López, Pablo Barragán, Pamela Soberanis Pina, Andres F Cardona, Jenny G Turcott
IMPORTANCE: Currently there is no standard therapy to improve cancer-related anorexia, hampering survival. Mirtazapine has been suggested as a feasible option in this context. OBJECTIVES: To assess the effect of mirtazapine on appetite and energy consumption in patients with advanced non-small cell lung cancer (NSCLC). DESIGN, SETTING, AND PARTICIPANTS: This randomized, double-blind, placebo-controlled clinical trial including adults was performed in a tertiary cancer care center from August 2018 to May 2022 with a follow-up of 8 weeks...
March 1, 2024: JAMA Oncology
https://read.qxmd.com/read/38197945/age-of-onset-for-increased-dose-adjusted-serum-concentrations-of-antidepressants-and-association-with-sex-and-genotype-an-observational-study-of-34-777-individuals
#44
JOURNAL ARTICLE
Kristine Tveit, Monica Hermann, Roy M Nilsen, Susanna M Wallerstedt, Arvid Rongve, Espen Molden, Kristine Hole
PURPOSE: The aim of this study was to examine the age of onset for increased dose-adjusted serum concentrations (C/D ratio) of common antidepressant drugs and to explore the potential association with sex and CYP2C19/CYP2D6 genotype. METHODS: Serum concentrations and prescribed daily doses for citalopram, escitalopram, sertraline, venlafaxine and mirtazapine, and CYP genotypes, were obtained from a therapeutic drug monitoring (TDM) service. Segmented linear regression analysis was used to examine the relationship between age and antidepressant log C/D ratio in (i) all individuals, (ii) men and women, and (iii) CYP2D6/CYP2C19 normal metabolizers (NMs) and CYP2D6/CYP2C19 intermediate or poor metabolizers (IMs/PMs)...
January 10, 2024: European Journal of Clinical Pharmacology
https://read.qxmd.com/read/38149637/development-of-a-novel-direct-compressible-co-processed-excipient-and-its-application-for-formulation-of-mirtazapine-orally-disintegrating-tablets
#45
JOURNAL ARTICLE
Ying Hui Loke, Yik-Ling Chew, Ashok Kumar Janakiraman, Siew-Keah Lee, A B M Helal Uddin, Choon Fu Goh, Phei Er Kee, Hui Suan Ng, Long Chiau Ming, Kai Bin Liew
INTRODUCTION: Orally disintegrating tablets (ODTs) are designed to dissolve in the oral cavity within 3 min, providing a convenient option for patients as they can be taken without water. Direct compression is the most common method used for ODTs formulations. However, the availability of single composite excipients with desirable characteristics such as good compressibility, fast disintegration, and a good mouthfeel suitable for direct compression is limited. OBJECTIVE: This research was proposed to develop a co-processed excipient composed of xylitol, mannitol, and microcrystalline cellulose for the formulation of ODTs...
December 27, 2023: Drug Development and Industrial Pharmacy
https://read.qxmd.com/read/38133585/drugs-for-depressionr
#46
JOURNAL ARTICLE
(no author information available yet)
No abstract text is available yet for this article.
December 11, 2023: Medical Letter on Drugs and Therapeutics
https://read.qxmd.com/read/38124123/changes-in-prescribing-of-psychotropic-vs-some-physical-health-medication-in-primary-care-through-the-covid-19-pandemic-in-england-a-national-level-survey
#47
JOURNAL ARTICLE
Unaiza Waheed, Mike Stedman, Mark Davies, Emma Solomon, David Taylor, Adrian Heald, Ram Prakash Narayanan, John Warner-Levy
INTRODUCTION: The COVID-19 pandemic globally impacted healthcare provision. Prescribing changes in common medications can be used as a marker for new diagnoses. We describe how the prescribing of specific psychotropics was impacted by the pandemic. METHODS: Primary Care Prescribing data for different classes of drugs from March 2017 to February 2022 were considered. To capture the impact during periods of restricted access to health services for new diagnoses/existing conditions, repeat prescriptions/episodic prescribing were included with account taken of historical trends...
December 21, 2023: Journal of Pharmaceutical Policy and Practice
https://read.qxmd.com/read/38111067/pharmacotherapy-for-attention-deficit-hyperactivity-disorder-in-youth-with-avoidant-restrictive-food-intake-disorder-a-case-series-of-patients-prescribed-stimulant-medication-in-a-partial-hospitalization-program-for-eating-disorders
#48
JOURNAL ARTICLE
Daphna M Finn, Jessie E Menzel, Emily Gray, Terry Schwartz
BACKGROUND: Appetite suppression and weight loss are established potential side effects of most medications for attention deficit/hyperactivity disorder (ADHD). These side effects may be especially problematic when using stimulants to treat ADHD in the context of a restrictive eating disorder, such as avoidant restrictive food intake disorder (ARFID), although these diagnoses are often comorbid in children. This paper presents a combined approach to treating ADHD comorbid with ARFID using stimulant medication and behavior management within a partial hospitalization program (PHP) and intensive outpatient program (IOP)for eating disorders...
December 18, 2023: Journal of Eating Disorders
https://read.qxmd.com/read/38083822/use-of-mirtazapine-in-the-treatment-of-canine-behaviour-problems-a-review-of-32-cases
#49
JOURNAL ARTICLE
Juan Argüelles, Blanca Duque, Marina Miralles, Jonathan Bowen, Jaume Fatjo
BACKGROUND: Canine behaviour problems seen by speciality behavioural medicine services often involve chronic anxiety disorders that have resulted in maladaptation of the individual to its environment. Common stressors include the presence of other individuals (other dogs or people), noise and being alone. The treatment of these behavioural problems usually includes a combination of behaviour modification, environmental modification and biological therapies. Within the latter, anxiolytic drugs such as clomipramine or fluoxetine have proven useful...
December 11, 2023: Veterinary Record
https://read.qxmd.com/read/38064630/effects-of-traditional-chinese-medicine-five-element-music-therapy-combined-with-mirtazapine-on-depression-and-limb-function-recovery-after-ischemic-stroke
#50
JOURNAL ARTICLE
Yechen Wu, Jiayin Li, Jian Qiao, Duo Jia, Kun Pang, Fan Yang, Jiawei Wang, Zhichao Zhang, Hongjing Yang, Xing Ju, Zheng Zhang, Xingsheng Wang
OBJECTIVE: To observe the effects of traditional Chinese medicine (TCM) five-element music therapy combined with mirtazapine on depression and limb function recovery after ischemic stroke. METHODS: A total of 110 patients treated in the Departments of Geriatrics, Cardiology, and Psychology of three hospitals in Qinhuangdao City, Hebei Province, China from October 2022 to August 2023 were selected. Based on the scores of 24-item Hamilton Depression Scale (HAMD-24), Barthel (BL) index, and National Institute of Health Stroke Scale (NIHSS) before enrollment, the patients were randomly divided into control group (n = 58) and experimental group (n = 52)...
December 8, 2023: Alternative Therapies in Health and Medicine
https://read.qxmd.com/read/38032000/comparative-safety-of-antidepressants-in-adults-with-ckd
#51
JOURNAL ARTICLE
Nanbo Zhu, Hong Xu, Tyra Lagerberg, Kristina Johnell, Juan Jesús Carrero, Zheng Chang
BACKGROUND: Depression is prevalent in patients with CKD and is related to poor prognosis. Despite the widespread use of antidepressants in the CKD population, their safety remains unclear. METHODS: We identified adults with CKD stages G3-5 (eGFR <60 ml/min per 1.73 m2 not treated with dialysis) and incident depression diagnosis during 2007-2019 from the Stockholm Creatinine Measurements project. Using the target trial emulation framework, we compared the following treatment strategies: (1) initiating versus not initiating antidepressants, (2) initiating mirtazapine versus selective serotonin reuptake inhibitors (SSRIs), and (3) initiating SSRIs with a lower dose versus a standard dose...
December 1, 2023: Clinical Journal of the American Society of Nephrology: CJASN
https://read.qxmd.com/read/38022834/optimizing-treatment-for-older-adults-with-depression
#52
REVIEW
Maytinee Srifuengfung, Bethany R Tellor Pennington, Eric J Lenze
This review presents a comprehensive guide for optimizing medication management in older adults with depression within an outpatient setting. Medication optimization involves tailoring the antidepressant strategy to the individual, ensuring the administration of appropriate medications at optimal dosages. In the case of older adults, this process necessitates not only adjusting or changing antidepressants but also addressing the concurrent use of inappropriate medications, many of which have cognitive side effects...
2023: Therapeutic Advances in Psychopharmacology
https://read.qxmd.com/read/38019131/sertraline-with-desvenlafaxine-and-sertraline-with-mirtazapine-as-treatment-initiation-in-mdd-patients-with-moderate-to-severe-depression-and-effect-on-inflammatory-markers
#53
JOURNAL ARTICLE
Norman Arockiaraj, Rachna Gupta, Rafat Ahmad, Sumita Halder, M S Bhatia
BACKGROUND: This study evaluated the effect of sertraline with desvenlafaxine and sertraline with mirtazapine on HAM-D score and inflammatory markers (IL-6 and TNF-α levels) in major depressive disorder. METHODS: Patients (18-60 years) with MDD diagnosed by DSM-V criteria and HAM-D score 18 or more were included ( n  = 60). Group A patients ( n  = 30) received sertraline 50 mg/day and desvenlafaxine 50 mg/day...
November 29, 2023: International Journal of Psychiatry in Clinical Practice
https://read.qxmd.com/read/38015216/obesity-management-in-adults-a-review
#54
REVIEW
Arielle Elmaleh-Sachs, Jessica L Schwartz, Carolyn T Bramante, Jacinda M Nicklas, Kimberly A Gudzune, Melanie Jay
IMPORTANCE: Obesity affects approximately 42% of US adults and is associated with increased rates of type 2 diabetes, hypertension, cardiovascular disease, sleep disorders, osteoarthritis, and premature death. OBSERVATIONS: A body mass index (BMI) of 25 or greater is commonly used to define overweight, and a BMI of 30 or greater to define obesity, with lower thresholds for Asian populations (BMI ≥25-27.5), although use of BMI alone is not recommended to determine individual risk...
November 28, 2023: JAMA
https://read.qxmd.com/read/38001492/discontinuation-of-antidepressant-treatment-a-retrospective-cohort-study-on-more-than-20-000-participants
#55
JOURNAL ARTICLE
Luis M Garcia-Marin, Aoibhe Mulcahy, Enda M Byrne, Sarah E Medland, Naomi R Wray, Freddy Chafota, Penelope A Lind, Nicholas G Martin, Ian B Hickie, Miguel E Rentería, Adrian I Campos
BACKGROUND: Factors influencing antidepressant treatment discontinuation are poorly understood. In the present study, we aimed to estimate the prevalence of antidepressant treatment discontinuation and identify demographic characteristics, psychiatric comorbidities, and specific side effects associated with treatment discontinuation. METHODS: We leveraged data from the Australian Genetics of Depression Study (AGDS; N = 20,941) to perform a retrospective cohort study on antidepressant treatment discontinuation...
November 24, 2023: Annals of General Psychiatry
https://read.qxmd.com/read/37992105/atypical-neuroleptic-malignant-syndrome-associated-with-mirtazapine-use
#56
Talha Ağaç, Hasan Gökçay, Mustafa Solmaz
No abstract text is available yet for this article.
2023: Psychiatria Danubina
https://read.qxmd.com/read/37987716/real-world-assessment-of-treatment-inertia-in-the-management-of-patients-treated-for-major-depressive-disorder-in-the-usa
#57
JOURNAL ARTICLE
John J Sheehan, Chris LaVallee, Keshia Maughn, Santosh Balakrishnan, Jacqueline A Pesa, Kruti Joshi, Craig Nelson
Aim: Major depressive disorder (MDD) is a debilitating illness in which depressive symptoms may persist after treatment. Treatment inertia is the continued use of the same pharmacotherapy regimen when treatment goals are not met. This study assessed the frequency of treatment inertia among adult patients with MDD treated in a real-world setting. Patients & methods: This was a retrospective, observational study of patients with MDD identified in the Decision Resources Group Real World Evidence US Data Repository from January 2014 to June 2018...
November 21, 2023: Journal of Comparative Effectiveness Research
https://read.qxmd.com/read/37986777/structural-insights-into-the-unexpected-agonism-of-tetracyclic-antidepressants-at-serotonin-receptors-5-ht-1e-r-and-5-ht-1f-r
#58
Gregory Zilberg, Alexandra K Parpounas, Audrey L Warren, Bianca Fiorillo, Davide Provasi, Marta Filizola, Daniel Wacker
Serotonin (5-hydroxytryptamine, 5-HT) acts via 13 different receptors in humans. Of these receptor subtypes, all but 5-HT 1e R have confirmed roles in native tissue and are validated drug targets. Despite 5-HT 1e R's therapeutic potential and plausible druggability, the mechanisms of its activation remain elusive. To illuminate 5-HT 1e R's pharmacology in relation to the highly homologous 5-HT 1F R, we screened a library of aminergic receptor ligands at both receptors and observe 5-HT 1e/1F R agonism by multicyclic drugs described as pan-antagonists at 5-HT receptors...
October 7, 2023: bioRxiv
https://read.qxmd.com/read/37970263/the-interface-between-depression-and-alzheimer-s-disease-a-comprehensive-approach
#59
JOURNAL ARTICLE
Pedro J Modrego, Leyre D de Cerio, Antonio Lobo
Depression and Alzheimer's disease (AD) are frequent interacting diseases in the elderly with a negative impact on the quality of life of patients and caregivers. Late-life depression may be regarded either as an early symptom of AD or a risk factor for AD, depending on the context. This review was focused on the latest developments in the fields of the neurobiological basis and treatment of depression in AD. We found that some plausible hypotheses are emerging to correlate with depression in AD, such as neuroinflammation and dysimmune regulation...
2023: Annals of Indian Academy of Neurology
https://read.qxmd.com/read/37965066/a-review-on-linking-stress-depression-and-insulin-resistance-via-low-grade-chronic-inflammation
#60
REVIEW
Seema Mehdi, Shahid Ud Din Wani, K L Krishna, Nabeel Kinattingal, Tamsheel Fatima Roohi
Stress is a disturbance in homeostasis caused by psychological, physiological, or environmental factors. Prolonged reactions to chronic stress can be detrimental, resulting in various metabolic abnormalities, referred to as metabolic syndrome (MS). There is a reciprocal increased risk between MS and major depressive disorder. Recent studies established an association between inflammation and insulin signaling in type 2 diabetes mellitus with depression. In the present review, we discuss chronic low-grade inflammation, pathways of insulin resistance, and brain glucose metabolism in the context of neuroinflammation and depression...
December 2023: Biochemistry and Biophysics Reports
keyword
keyword
67229
3
4
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.